Francois Nader Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Francois Nader is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TALS, which is worth approximately $0. The most recent transaction as insider was on Jul 25, 2022, when has been sold 138,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Francois Nader Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2022
SELL
Other acquisition or disposition
-
138,500 Reduced 100.0%
0 Common Stock
Jul 21 2022
BUY
Open market or private purchase
$135,780 $3.72 p/Share
36,500 Added 20.86%
138,500 Common Stock
Jul 20 2022
BUY
Open market or private purchase
$188,240 $3.62 p/Share
52,000 Added 33.77%
102,000 Common Stock
Jul 19 2022
BUY
Open market or private purchase
$176,000 $3.52 p/Share
50,000 Added 50.0%
50,000 Common Stock

Also insider at

MRNA
Moderna, Inc. Healthcare
Director
PRVL
Prevail Therapeutics Inc.
Director
XLRN
ACCELERON PHARMA INC Healthcare
Director
ALXN
ALEXION PHARMACEUTICALS, INC.
Director
FN

Francois Nader

Director
Cambridge, MA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS